Literature DB >> 27512445

Trends in maternal deaths from epilepsy in the United Kingdom: a 30-year retrospective review.

Dipanwita Kapoor1, Suzanne Wallace1.   

Abstract

OBJECTIVE: Neurological diseases remain the second most common cause of maternal mortality from indirect causes, according to the last United Kingdom confidential enquiry into maternal death. The maternal mortality rate from epilepsy is reported as 0.61 per 100,000 maternities. The aim of this study was to analyse the trends and causes of maternal death from epilepsy in the UK over the last 30 years. Information on sub-standard care associated with fatalities was also consolidated to inform guidance and clinical care by obstetricians and physicians caring for pregnant women with epilepsy. STUDY
DESIGN: A retrospective review of 10 triennial confidential enquiry into maternal death reports (1979-2008) was performed, encompassing 21,514,457 maternities. Late and coincidental deaths were not included in the analyses.
RESULTS: Between 1979 and 2008, there were 92 maternal deaths from epilepsy. The proportion of total maternal deaths from epilepsy over 30 years is 3.7% (95% CI 3.0-4.5), which showed an increasing trend. Sudden unexpected death in epilepsy remains the single greatest cause of maternal death from epilepsy followed by aspiration of gastric contents during seizures and drowning during bathing.
CONCLUSION: All women with epilepsy should be looked after by specialist combined obstetric and medical or neurological teams in pregnancy to improve maternal and fetal outcomes.

Entities:  

Keywords:  Maternal mortality; high-risk pregnancy; neurology

Year:  2014        PMID: 27512445      PMCID: PMC4934988          DOI: 10.1177/1753495X14553257

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  22 in total

Review 1.  Maternal death from stroke: a thirty year national retrospective review.

Authors:  Lin Foo; Susan Bewley; Anthony Rudd
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-09-29       Impact factor: 2.435

2.  SUDEP and epilepsy-related mortality in pregnancy.

Authors:  Stephan Edey; Nicholas Moran; Lina Nashef
Journal:  Epilepsia       Date:  2014-04-22       Impact factor: 5.864

3.  Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death.

Authors:  J F Annegers; S P Coan; W A Hauser; J Leestma
Journal:  Epilepsia       Date:  2000-05       Impact factor: 5.864

4.  Sudden unexpected death in epilepsy (SUDEP): a clinical perspective and a search for risk factors.

Authors:  R Kloster; T Engelskjøn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

5.  Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom.

Authors:  Roch Cantwell; Thomas Clutton-Brock; Griselda Cooper; Andrew Dawson; James Drife; Debbie Garrod; Ann Harper; Diana Hulbert; Sebastian Lucas; John McClure; Harry Millward-Sadler; James Neilson; Catherine Nelson-Piercy; Jane Norman; Colm O'Herlihy; Margaret Oates; Judy Shakespeare; Michael de Swiet; Catherine Williamson; Valerie Beale; Marian Knight; Christopher Lennox; Alison Miller; Dharmishta Parmar; Jane Rogers; Anna Springett
Journal:  BJOG       Date:  2011-03       Impact factor: 6.531

6.  Sudden unexpected death in epilepsy: terminology and definitions.

Authors:  L Nashef
Journal:  Epilepsia       Date:  1997-11       Impact factor: 5.864

7.  Lamotrigine clearance during pregnancy.

Authors:  T A Tran; I E Leppik; K Blesi; S T Sathanandan; R Remmel
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

8.  Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.

Authors:  Inger Ohman; Olof Beck; Sigurd Vitols; Torbjörn Tomson
Journal:  Epilepsia       Date:  2007-12-11       Impact factor: 5.864

9.  Population-based study of the incidence of sudden unexplained death in epilepsy.

Authors:  D M Ficker; E L So; W K Shen; J F Annegers; P C O'Brien; G D Cascino; P G Belau
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

10.  Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

Authors:  P B Pennell; L Peng; D J Newport; J C Ritchie; A Koganti; D K Holley; M Newman; Z N Stowe
Journal:  Neurology       Date:  2007-11-28       Impact factor: 9.910

View more
  3 in total

Review 1.  Valproate: life-saving, life-changing.

Authors:  Rhys H Thomas
Journal:  Clin Med (Lond)       Date:  2018-04-01       Impact factor: 2.659

2.  Therapeutic levetiracetam monitoring during pregnancy: "mind the gap".

Authors:  Maya Berlin; Dana Barchel; Revital Gandelman-Marton; Nurit Brandriss; Ilan Blatt; Tomer Ziv-Baran; Miri Y Neufeld; Natalie Dinavitser; Elkana Kohn; Dotan Shaniv; Tal De-Haan; Fanny Ofek; Gideon Koren; David Stepensky; Matitiahu Berkovitch
Journal:  Ther Adv Chronic Dis       Date:  2019-05-27       Impact factor: 5.091

3.  Are doses of lamotrigine or levetiracetam adjusted during pregnancy?

Authors:  Noni Richards; David Reith; Michael Stitely; Alesha Smith
Journal:  Epilepsia Open       Date:  2017-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.